CTEV peer analysis
Claritev (CTEV) against its competitors: price, today's move, 1-year return and market value side by side.
CTEV and its peers
| Company | Price | Today | 1-year return | Market cap |
|---|---|---|---|---|
| AXGN Axogen | $50.69 | 1.34% | 111.30% | $3.03B |
| DNTH Dianthus Therapeutics | $89.90 | 4.50% | 146.77% | $5.06B |
| EVH Evolent Health | $4.67 | 1.97% | -22.17% | $528.20M |
| GDRX GoodRx | $3.65 | 3.99% | 15.51% | $1.25B |
| IART Integra LifeSciences | $14.39 | 7.23% | 28.25% | $1.12B |
| INMD InMode | $13.51 | 1.31% | -6.48% | $777.13M |
| IRMD iRadimed | $86.55 | 0.28% | 2.28% | $1.11B |
| LFMD LifeMD | $2.10 | -11.60% | -60.17% | $101.10M |
| OPK Opko Health | $1.70 | -1.73% | 23.19% | $1.26B |
| SANA Sana | $2.45 | 3.38% | -39.51% | $734.11M |
| CTEV Claritev | $24.10 | 6.12% | -61.10% | $408.43M |
- CTEV's peers: AXGN (Axogen), DNTH (Dianthus Therapeutics), EVH (Evolent Health), GDRX (GoodRx), IART (Integra LifeSciences), INMD (InMode), IRMD (iRadimed), LFMD (LifeMD).
Updated 2026-11-10 04:46 UTC